PART I Overview We are a clinical-stage biotechnology company focused on unlocking the broad potential of ribonucleic acid (RNA) medicines (also known as oligonucleotides), or those targeting RNA, to transform human health. Our RNA medicines platform, PRISM , combines multiple modalities, chemistry innovation and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and common disorders. Our toolkit of RNA-targeting modalities, including RNAi (SpiNA) and RNA ...
Q2 FY2026 — expected 2026-09-14
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-26 | 2025-12-31 | 0001193125-26-073472 | EDGAR | 97K words |
| 2025-03-04 | 2024-12-31 | 0000950170-25-031322 | EDGAR | — |
| 2024-03-06 | 2023-12-31 | 0000950170-24-026876 | EDGAR | — |
| 2023-03-23 | 2022-12-31 | 0000950170-23-009319 | EDGAR | — |
| 2022-03-03 | 2021-12-31 | 0001564590-22-008414 | EDGAR | — |
| 2021-03-04 | 2020-12-31 | 0001564590-21-010718 | EDGAR | — |
| 2020-03-02 | 2019-12-31 | 0001564590-20-007972 | EDGAR | — |
| 2019-03-01 | 2018-12-31 | 0001564590-19-005671 | EDGAR | — |
| 2018-03-12 | 2017-12-31 | 0001564590-18-005308 | EDGAR | — |
| 2017-03-16 | 2016-12-31 | 0001564590-17-004649 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-07-30 | 2026-06-30 | 0001193125-26-324949 | EDGAR | — |
| 2025-11-10 | 2025-09-30 | 0001193125-25-273288 | EDGAR | 23K words |
| 2025-07-30 | 2025-06-30 | 0000950170-25-099884 | EDGAR | — |
| 2025-05-08 | 2025-03-31 | 0000950170-25-066404 | EDGAR | — |
| 2024-11-12 | 2024-09-30 | 0000950170-24-124595 | EDGAR | — |
| 2024-08-08 | 2024-06-30 | 0000950170-24-093341 | EDGAR | — |
| 2024-05-10 | 2024-03-31 | 0000950170-24-057457 | EDGAR | — |
| 2023-11-09 | 2023-09-30 | 0000950170-23-061544 | EDGAR | — |
| 2023-08-03 | 2023-06-30 | 0000950170-23-037601 | EDGAR | — |
| 2023-05-03 | 2023-03-31 | 0000950170-23-016888 | EDGAR | — |
| 2022-11-10 | 2022-09-30 | 0000950170-22-024171 | EDGAR | — |
| 2022-08-11 | 2022-06-30 | 0000950170-22-016653 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-07-30 | 0001193125-26-324917 | EDGAR | — |
| 2026-03-26 | 0001193125-26-125092 | EDGAR | 2K words |
| 2026-02-26 | 0001193125-26-073437 | EDGAR | — |
| 2026-02-02 | 0001193125-26-032698 | EDGAR | — |
| 2026-01-12 | 0001193125-26-009784 | EDGAR | — |
| 2025-12-11 | 0001193125-25-314746 | EDGAR | — |
| 2025-12-08 | 0001193125-25-310595 | EDGAR | — |
| 2025-11-17 | 0001193125-25-283929 | EDGAR | — |
| 2025-11-10 | 0001193125-25-273278 | EDGAR | — |
| 2025-10-29 | 0001193125-25-256682 | EDGAR | — |
244 total filings indexed. 212 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001631574 |
| Ticker | WVE |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | U0 |
| Website | https://www.wavelifesciences.com |
| Listed | 2015-11-11 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/WVE (~200 tokens, structured JSON with cryptographic provenance)